At Kid Risk, we focus on improving children's lives by understanding, characterizing, and communicating about the real risks that children face around the world, and on empowering policy makers, parents, kids, and others to use the best available information and analytical insights as we do our best for children. We recognize that managing risks is the key to realizing the best possible futures for everyone. Learn more about our mission and organization and meet our team.

Kid Risk currently focuses its research on managing the risks associated with polioviruses (read an overview) and characterizing the benefits of global investments in measles and rubella immunization. We receive funding for our research from the U.S. Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and the Bill & Melinda Gates Foundation. Our research demonstrates that investments in public health save lives and money.

October 21, 2016 - Read about our extensive research and our recent analyses of the potential benefits of new poliovirus vaccines, and the importantance of screening and polio antiviral drugs for long-term immunocompromised vaccine-derived poliovirus excretors, maintaining high coverage with bivalent oral poliovirus vaccine (bOPV) in the run-up to globally-coordinated cessation of bOPV, and cost uncertainty in estimates of future polio endgame costs and benefits. Check out an interview by Wycliffe Muga (pdf in English or traduction en français), award-winning reporter and Weekend Editor of The Star in Kenya, with Dr. Thompson about a recent meeting of African Ministers of Health and Finance. You can also check out our other news and learn more about our extensive research.

Join our mailing list to receive press releases and/or periodic updates about our work. Thank you to all of our supporters.